HSBC Reports Taiwan Semi (TSM) Upgrade; Nuvasive (NUVA) SI Decreased By 2.96%

January 16, 2018 - By Evgen Dobrzhanskiy

Among 8 analysts covering Taiwan Semiconductor Manufacturing (NYSE:TSM), 2 have Buy rating, 0 Sell and 6 Hold. Therefore 25% are positive. Taiwan Semiconductor Manufacturing has $26 highest and $14 lowest target. $21’s average target is -49.02% below currents $41.19 stock price. Taiwan Semiconductor Manufacturing had 12 analyst reports since August 24, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, September 6 by KeyBanc Capital Markets. The firm has “Outperform” rating given on Friday, December 11 by Credit Suisse. The stock of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) has “Neutral” rating given on Tuesday, June 28 by Goldman Sachs. Susquehanna upgraded Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) on Tuesday, October 4 to “Neutral” rating. As per Friday, October 14, the company rating was upgraded by Pacific Crest. J.P. Morgan upgraded the shares of TSM in report on Tuesday, October 10 to “Buy” rating. On Wednesday, June 21 the stock rating was downgraded by HSBC to “Hold”. The stock has “Hold” rating by HSBC on Thursday, October 13. The stock of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) earned “Equal-Weight” rating by Morgan Stanley on Monday, November 27.

Nuvasive Incorporated (NASDAQ:NUVA) had a decrease of 2.96% in short interest. NUVA’s SI was 5.73 million shares in January as released by FINRA. Its down 2.96% from 5.90M shares previously. With 555,100 avg volume, 10 days are for Nuvasive Incorporated (NASDAQ:NUVA)’s short sellers to cover NUVA’s short positions. The SI to Nuvasive Incorporated’s float is 11.43%. The stock increased 1.60% or $0.84 during the last trading session, reaching $53.33. About 1.56 million shares traded or 78.63% up from the average. NuVasive, Inc. (NASDAQ:NUVA) has risen 33.31% since January 16, 2017 and is uptrending. It has outperformed by 16.61% the S&P500.

NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. The company has market cap of $2.72 billion. The Company’s products focus on applications for spine fusion surgery, including biologics used for spinal fusion process. It has a 45.82 P/E ratio. The companyÂ’s principal product is Maximum Access Surgery, a minimally-disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics.

Among 22 analysts covering Nuvasive Inc. (NASDAQ:NUVA), 19 have Buy rating, 0 Sell and 3 Hold. Therefore 86% are positive. Nuvasive Inc. had 63 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of NuVasive, Inc. (NASDAQ:NUVA) has “Buy” rating given on Friday, November 10 by RBC Capital Markets. The stock of NuVasive, Inc. (NASDAQ:NUVA) earned “Buy” rating by Canaccord Genuity on Monday, September 11. Wells Fargo maintained the shares of NUVA in report on Wednesday, October 25 with “Outperform” rating. RBC Capital Markets maintained the shares of NUVA in report on Tuesday, July 18 with “Buy” rating. The rating was maintained by BMO Capital Markets on Wednesday, October 25 with “Outperform”. The rating was maintained by RBC Capital Markets on Monday, October 9 with “Buy”. The company was upgraded on Thursday, January 4 by Needham. On Monday, October 23 the stock rating was maintained by Canaccord Genuity with “Buy”. The stock of NuVasive, Inc. (NASDAQ:NUVA) has “Buy” rating given on Wednesday, August 16 by Canaccord Genuity. Robert W. Baird downgraded the shares of NUVA in report on Friday, July 28 to “Neutral” rating.

Since August 17, 2017, it had 0 insider purchases, and 1 insider sale for $256,621 activity. On Thursday, August 17 the insider HOWE LESLEY H sold $256,621.

Investors sentiment decreased to 0.95 in 2017 Q3. Its down 0.28, from 1.23 in 2017Q2. It fall, as 67 investors sold NuVasive, Inc. shares while 69 reduced holdings. 47 funds opened positions while 82 raised stakes. 53.88 million shares or 3.45% less from 55.81 million shares in 2017Q2 were reported. 820,598 are owned by Northern. Sense Advisors owns 19,246 shares for 0.55% of their portfolio. 7,411 are held by Commonwealth Of Pennsylvania School Empls Retrmt System. Sei reported 173,533 shares. Hightower Advsr Limited Co reported 109,664 shares. Rainier Mngmt Llc accumulated 79,800 shares. Nationwide Fund invested in 0.08% or 356,751 shares. Mutual Of America Cap Mgmt Ltd Liability Com invested in 0.06% or 63,108 shares. Alliancebernstein Limited Partnership has invested 0% in NuVasive, Inc. (NASDAQ:NUVA). Winslow Evans And Crocker has 2,000 shares for 0.04% of their portfolio. Gamco Investors Et Al holds 0.06% of its portfolio in NuVasive, Inc. (NASDAQ:NUVA) for 178,808 shares. Fortaleza Asset Inc has invested 0.12% of its portfolio in NuVasive, Inc. (NASDAQ:NUVA). Royal Bank Of Canada reported 1.06M shares or 0.03% of all its holdings. Millennium Lc owns 40,421 shares or 0% of their US portfolio. California State Teachers Retirement Systems reported 0.01% of its portfolio in NuVasive, Inc. (NASDAQ:NUVA).